ACTR-16. PERIPHERAL BLOOD CD4+ MONONUCLEAR CELL FRACTIONS ARE ASSOCIATED WITH OVERALL SURVIVAL AT FIRST RECURRENCE OF IDH-WILDTYPE GLIOBLASTOMA AFTER STANDARD CHEMORADIOTHERAPY: SECONDARY ANALYSES OF THE PHASE II DIRECTOR TRIAL

The alkylating agent temozolomide prolongs survival of glioblastoma patients through induction of futile DNA mismatch repair in cancer cells. Whether systemic temozolomide effects on the immune system affect outcome has not been studied in detail. To address this question, we analyzed peripheral blo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro Oncol
Hauptverfasser: Wirsching, Hans-Georg, Terksikh, Ekaterina, Silginer, Manuela, Krieg, Carsten, Tabatabai, Ghazaleh, Wick, Wolfgang, Reifenberger, Guido, Roth, Patrick, Becher, Burkhard, Weller, Michael
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2018
Schlagworte:
Abstracts
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216167/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.050
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge